Publications by authors named "M Teresa Belver"
The comprehensive psychosocial assessment of children with cancer requires listening to them and understanding their point of view. The objective of this work was to know what the participating children with cancer thought about the hospital, which they considered to be the best and worst aspects of their experience. We conducted a qualitative study using semi-structured interviews with 27 children with cancer.
View Article and Find Full Text PDFArticle Synopsis
- Allergic diseases are immunological disorders triggered by allergens, leading to type 2 immunity and IgE responses, with a rising prevalence similar to cardiovascular diseases (CVD).
- CVD often stems from atherosclerosis, characterized by endothelial dysfunction and Th1 inflammation, raising questions about the relationship between allergic conditions and heart health.
- The review explores the phases of allergic pathology, immunological mechanisms of atherosclerosis, and the complex clinical connections between allergic diseases (like asthma and food allergies) and CVD, including the role of various immune cells and mediators in these conditions.
Selective Allergy to Wedge Sole (Dicologlossa cuneata) due to ß-Parvalbumin.
J Investig Allergol Clin Immunol
February 2023
Article Synopsis
- Lung cancer is a big problem, causing about 25% of cancer deaths, and this study looked at if men and women show different signs of it when they're diagnosed.
- Researchers analyzed data from a large group of lung cancer patients in Spain and found that women were usually younger and smoked less than men.
- In the end, the study showed that there weren't many differences between men and women when it came to how advanced their cancer was or what symptoms they had when diagnosed.
Colorectal cancer (CRC) is a global public health problem as it is the third most prevalent and the second most lethal cancer worldwide. Major efforts are underway to understand its molecular pathways as well as to define the tumour-associated antigens (TAAs) and tumour-specific antigens (TSAs) or neoantigens, in order to develop an effective treatment. Cell therapies are currently gaining importance, and more specifically chimeric antigen receptor (CAR)-T cell therapy, in which genetically modified T cells are redirected against the tumour antigen of interest.
View Article and Find Full Text PDF